VYRALYM Trademark

Trademark Overview

On Monday, March 16, 2020, a trademark application was filed for VYRALYM with the United States Patent and Trademark Office. The USPTO has given the VYRALYM trademark a serial number of 88835867. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Allovir, Inc.. The VYRALYM trademark is filed in the Pharmaceutical Products category with the following description:

Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders
vyralym

General Information

Serial Number88835867
Word MarkVYRALYM
Filing DateMonday, March 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesCell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllovir, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameAllovir, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77098

Trademark Events

Event DateEvent Description
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023SOU EXTENSION 5 GRANTED
Thursday, February 16, 2023SOU EXTENSION 5 FILED
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU EXTENSION 4 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 4 FILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2022SOU EXTENSION 3 GRANTED
Thursday, February 17, 2022SOU EXTENSION 3 FILED
Thursday, February 17, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 1, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 1, 2021SOU EXTENSION 2 FILED
Wednesday, September 1, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 18, 2021SOU EXTENSION 1 GRANTED
Monday, March 15, 2021SOU EXTENSION 1 FILED
Tuesday, May 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 20, 2021NOTICE OF REVIVAL - E-MAILED
Monday, April 19, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, April 19, 2021PETITION TO REVIVE-GRANTED
Monday, April 19, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, April 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 19, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 8, 2020ASSIGNED TO EXAMINER
Friday, March 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 19, 2020NEW APPLICATION ENTERED

Related Keywords

vyralym pharmaceutical treatment products diseases respiratory cancer viral treating system preparations